TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Pediatric Drugs Market Research Report 2023

Global Pediatric Drugs Market Research Report 2023

  • Category:Life Sciences
  • Published on : 27 December 2022
  • Pages :104
  • Formats:
  • Report Code:SMR-7521404
OfferClick for best price

Best Price: $2320

Pediatric Drugs Market Size, Share 2022


Market Analysis and Insights: Global Pediatric Drugs Market

The global Pediatric Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Drugs market.

Global Pediatric Drugs Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Allergy and Respiratory Drugs

Anti-Infectives

Cancer Therapies

Cardiovascular Drugs

Central Nervous System Drugs

Gastrointestinal Drugs

Hormone Drugs

Urological Drugs

Segment by Application

Hospital

Clinic

Drugstore

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Abbott Laboratories

Bayer

Boehringer Ingelheim

Bristol-Myers Squibb

Colgate Oral Pharmaceuticals

Eli Lilly

Forest Laboratories

Genentech

GlaxoSmithKline

Johnson & Johnson

MedImmune

Merck

Novartis Pharmaceuticals

Novo Nordisk

Pfizer

Pharmacia

Roche

Schering-Plough

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Pediatric Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Pediatric Drugs, with price, sales, revenue, and global market share of Pediatric Drugs from 2019 to 2022.

Chapter 3, the Pediatric Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pediatric Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pediatric Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Drugs.

Chapter 13, 14, and 15, to describe Pediatric Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Pediatric Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Pediatric Drugs Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 104 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Pediatric Drugs Market Overview
1.1 Product Overview and Scope of Pediatric Drugs
1.2 Pediatric Drugs Segment by Type
1.2.1 Global Pediatric Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Allergy and Respiratory Drugs
1.2.3 Anti-Infectives
1.2.4 Cancer Therapies
1.2.5 Cardiovascular Drugs
1.2.6 Central Nervous System Drugs
1.2.7 Gastrointestinal Drugs
1.2.8 Hormone Drugs
1.2.9 Urological Drugs
1.3 Pediatric Drugs Segment by Application
1.3.1 Global Pediatric Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Pediatric Drugs Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs Revenue 2018-2030
1.4.2 Global Pediatric Drugs Sales 2018-2030
1.4.3 Pediatric Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 Pediatric Drugs Market Competition by Manufacturers
2.1 Global Pediatric Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Pediatric Drugs Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Drugs Market Competitive Situation and Trends
2.5.1 Pediatric Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs Players Market Share by Revenue
2.5.3 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Drugs Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Pediatric Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Pediatric Drugs Market Facts & Figures by Country
3.3.1 North America Pediatric Drugs Sales by Country
3.3.2 North America Pediatric Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Drugs Market Facts & Figures by Country
3.4.1 Europe Pediatric Drugs Sales by Country
3.4.2 Europe Pediatric Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Drugs Sales by Region
3.5.2 Asia Pacific Pediatric Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Drugs Market Facts & Figures by Country
3.6.1 Latin America Pediatric Drugs Sales by Country
3.6.2 Latin America Pediatric Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Drugs Sales by Country
3.7.2 Middle East and Africa Pediatric Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Drugs Historic Market Analysis by Type
4.1 Global Pediatric Drugs Sales Market Share by Type (2018-2023)
4.2 Global Pediatric Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Pediatric Drugs Price by Type (2018-2023)
5 Global Pediatric Drugs Historic Market Analysis by Application
5.1 Global Pediatric Drugs Sales Market Share by Application (2018-2023)
5.2 Global Pediatric Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Pediatric Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Pediatric Drugs Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Pediatric Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Pediatric Drugs Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Pediatric Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Colgate Oral Pharmaceuticals
6.5.1 Colgate Oral Pharmaceuticals Corporation Information
6.5.2 Colgate Oral Pharmaceuticals Description and Business Overview
6.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio
6.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eli Lilly Pediatric Drugs Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Forest Laboratories
6.6.1 Forest Laboratories Corporation Information
6.6.2 Forest Laboratories Description and Business Overview
6.6.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Forest Laboratories Pediatric Drugs Product Portfolio
6.7.5 Forest Laboratories Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Corporation Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Genentech Pediatric Drugs Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GlaxoSmithKline Pediatric Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Johnson & Johnson Pediatric Drugs Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Corporation Information
6.11.2 MedImmune Pediatric Drugs Description and Business Overview
6.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 MedImmune Pediatric Drugs Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Pediatric Drugs Description and Business Overview
6.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Merck Pediatric Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Novartis Pharmaceuticals
6.13.1 Novartis Pharmaceuticals Corporation Information
6.13.2 Novartis Pharmaceuticals Pediatric Drugs Description and Business Overview
6.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Novartis Pharmaceuticals Pediatric Drugs Product Portfolio
6.13.5 Novartis Pharmaceuticals Recent Developments/Updates
6.14 Novo Nordisk
6.14.1 Novo Nordisk Corporation Information
6.14.2 Novo Nordisk Pediatric Drugs Description and Business Overview
6.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Novo Nordisk Pediatric Drugs Product Portfolio
6.14.5 Novo Nordisk Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Pediatric Drugs Description and Business Overview
6.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pfizer Pediatric Drugs Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Pharmacia
6.16.1 Pharmacia Corporation Information
6.16.2 Pharmacia Pediatric Drugs Description and Business Overview
6.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pharmacia Pediatric Drugs Product Portfolio
6.16.5 Pharmacia Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Pediatric Drugs Description and Business Overview
6.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Roche Pediatric Drugs Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 Schering-Plough
6.18.1 Schering-Plough Corporation Information
6.18.2 Schering-Plough Pediatric Drugs Description and Business Overview
6.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Schering-Plough Pediatric Drugs Product Portfolio
6.18.5 Schering-Plough Recent Developments/Updates
7 Pediatric Drugs Manufacturing Cost Analysis
7.1 Pediatric Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Drugs
7.4 Pediatric Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Drugs Distributors List
8.3 Pediatric Drugs Customers
9 Pediatric Drugs Market Dynamics
9.1 Pediatric Drugs Industry Trends
9.2 Pediatric Drugs Market Drivers
9.3 Pediatric Drugs Market Challenges
9.4 Pediatric Drugs Market Restraints
10 Global Market Forecast
10.1 Pediatric Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Pediatric Drugs by Type (2023-2030)
10.2 Pediatric Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Pediatric Drugs by Application (2023-2030)
10.3 Pediatric Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Pediatric Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Pediatric Drugs Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Pediatric Drugs Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Pediatric Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Pediatric Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Pediatric Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Pediatric Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pediatric Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Pediatric Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Pediatric Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Pediatric Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Pediatric Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pediatric Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global Pediatric Drugs Sales Market Share by Region (2018-2023)
Table 17. Global Pediatric Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Pediatric Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 20. North America Pediatric Drugs Sales Market Share by Country (2018-2023)
Table 21. North America Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Pediatric Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 24. Europe Pediatric Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Pediatric Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Pediatric Drugs Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Pediatric Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Pediatric Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Pediatric Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Pediatric Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Pediatric Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Pediatric Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Pediatric Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Global Pediatric Drugs Sales Market Share by Type (2018-2023)
Table 41. Global Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Pediatric Drugs Revenue Share by Type (2018-2023)
Table 43. Global Pediatric Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Pediatric Drugs Sales (K Units) by Application (2018-2023)
Table 45. Global Pediatric Drugs Sales Market Share by Application (2018-2023)
Table 46. Global Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Pediatric Drugs Revenue Share by Application (2018-2023)
Table 48. Global Pediatric Drugs Price by Application (2018-2023) & (USD/Unit)
Table 49. Abbott Laboratories Corporation Information
Table 50. Abbott Laboratories Description and Business Overview
Table 51. Abbott Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Abbott Laboratories Pediatric Drugs Product
Table 53. Abbott Laboratories Recent Developments/Updates
Table 54. Bayer Corporation Information
Table 55. Bayer Description and Business Overview
Table 56. Bayer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Bayer Pediatric Drugs Product
Table 58. Bayer Recent Developments/Updates
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Description and Business Overview
Table 61. Boehringer Ingelheim Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Boehringer Ingelheim Pediatric Drugs Product
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Bristol-Myers Squibb Corporation Information
Table 65. Bristol-Myers Squibb Description and Business Overview
Table 66. Bristol-Myers Squibb Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Bristol-Myers Squibb Pediatric Drugs Product
Table 68. Bristol-Myers Squibb Recent Developments/Updates
Table 69. Colgate Oral Pharmaceuticals Corporation Information
Table 70. Colgate Oral Pharmaceuticals Description and Business Overview
Table 71. Colgate Oral Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Colgate Oral Pharmaceuticals Pediatric Drugs Product
Table 73. Colgate Oral Pharmaceuticals Recent Developments/Updates
Table 74. Eli Lilly Corporation Information
Table 75. Eli Lilly Description and Business Overview
Table 76. Eli Lilly Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Eli Lilly Pediatric Drugs Product
Table 78. Eli Lilly Recent Developments/Updates
Table 79. Forest Laboratories Corporation Information
Table 80. Forest Laboratories Description and Business Overview
Table 81. Forest Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Forest Laboratories Pediatric Drugs Product
Table 83. Forest Laboratories Recent Developments/Updates
Table 84. Genentech Corporation Information
Table 85. Genentech Description and Business Overview
Table 86. Genentech Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Genentech Pediatric Drugs Product
Table 88. Genentech Recent Developments/Updates
Table 89. GlaxoSmithKline Corporation Information
Table 90. GlaxoSmithKline Description and Business Overview
Table 91. GlaxoSmithKline Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. GlaxoSmithKline Pediatric Drugs Product
Table 93. GlaxoSmithKline Recent Developments/Updates
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Business Overview
Table 96. Johnson & Johnson Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Johnson & Johnson Pediatric Drugs Product
Table 98. Johnson & Johnson Recent Developments/Updates
Table 99. MedImmune Corporation Information
Table 100. MedImmune Description and Business Overview
Table 101. MedImmune Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. MedImmune Pediatric Drugs Product
Table 103. MedImmune Recent Developments/Updates
Table 104. Merck Corporation Information
Table 105. Merck Description and Business Overview
Table 106. Merck Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Merck Pediatric Drugs Product
Table 108. Merck Recent Developments/Updates
Table 109. Novartis Pharmaceuticals Corporation Information
Table 110. Novartis Pharmaceuticals Description and Business Overview
Table 111. Novartis Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Novartis Pharmaceuticals Pediatric Drugs Product
Table 113. Novartis Pharmaceuticals Recent Developments/Updates
Table 114. Novo Nordisk Corporation Information
Table 115. Novo Nordisk Description and Business Overview
Table 116. Novo Nordisk Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Novo Nordisk Pediatric Drugs Product
Table 118. Novo Nordisk Recent Developments/Updates
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Business Overview
Table 121. Pfizer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Pfizer Pediatric Drugs Product
Table 123. Pfizer Recent Developments/Updates
Table 124. Pharmacia Corporation Information
Table 125. Pharmacia Description and Business Overview
Table 126. Pharmacia Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Pharmacia Pediatric Drugs Product
Table 128. Pharmacia Recent Developments/Updates
Table 129. Roche Corporation Information
Table 130. Roche Description and Business Overview
Table 131. Roche Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Roche Pediatric Drugs Product
Table 133. Roche Recent Developments/Updates
Table 134. Schering-Plough Corporation Information
Table 135. Schering-Plough Description and Business Overview
Table 136. Schering-Plough Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Schering-Plough Pediatric Drugs Product
Table 138. Schering-Plough Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Pediatric Drugs Distributors List
Table 142. Pediatric Drugs Customers List
Table 143. Pediatric Drugs Market Trends
Table 144. Pediatric Drugs Market Drivers
Table 145. Pediatric Drugs Market Challenges
Table 146. Pediatric Drugs Market Restraints
Table 147. Global Pediatric Drugs Sales Forecast by Type (2023-2030) & (K Units)
Table 148. Global Pediatric Drugs Sales Market Share Forecast by Type (2023-2030)
Table 149. Global Pediatric Drugs Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 150. Global Pediatric Drugs Revenue Market Share Forecast by Type (2023-2030)
Table 151. Global Pediatric Drugs Sales Forecast by Application (2023-2030) & (K Units)
Table 152. Global Pediatric Drugs Sales Market Share Forecast by Application (2023-2030)
Table 153. Global Pediatric Drugs Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 154. Global Pediatric Drugs Revenue Market Share Forecast by Application (2023-2030)
Table 155. Global Pediatric Drugs Sales Forecast by Region (2023-2030) & (K Units)
Table 156. Global Pediatric Drugs Sales Market Share Forecast by Region (2023-2030)
Table 157. Global Pediatric Drugs Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 158. Global Pediatric Drugs Revenue Market Share Forecast by Region (2023-2030)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Drugs
Figure 2. Global Pediatric Drugs Market Share by Type in 2022 & 2030
Figure 3. Allergy and Respiratory Drugs Product Picture
Figure 4. Anti-Infectives Product Picture
Figure 5. Cancer Therapies Product Picture
Figure 6. Cardiovascular Drugs Product Picture
Figure 7. Central Nervous System Drugs Product Picture
Figure 8. Gastrointestinal Drugs Product Picture
Figure 9. Hormone Drugs Product Picture
Figure 10. Urological Drugs Product Picture
Figure 11. Global Pediatric Drugs Market Share by Application in 2022 & 2030
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Drugstore
Figure 15. Global Pediatric Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 16. Global Pediatric Drugs Market Size (2018-2030) & (US$ Million)
Figure 17. Global Pediatric Drugs Sales (2018-2030) & (K Units)
Figure 18. Pediatric Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Pediatric Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Pediatric Drugs Players: Market Share by Revenue in 2022
Figure 21. Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Pediatric Drugs Sales Market Share by Region (2018-2023)
Figure 23. Global Pediatric Drugs Sales Market Share by Region in 2022
Figure 24. Global Pediatric Drugs Revenue Market Share by Region (2018-2023)
Figure 25. Global Pediatric Drugs Revenue Market Share by Region in 2022
Figure 26. U.S. Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Canada Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Germany Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. France Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. U.K. Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Italy Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Russia Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. China Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Japan Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. South Korea Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. India Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Australia Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Taiwan Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Indonesia Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Thailand Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Malaysia Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Philippines Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Vietnam Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Mexico Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Brazil Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Argentina Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. Turkey Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Saudi Arabia Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 49. U.A.E Pediatric Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 50. Sales Market Share of Pediatric Drugs by Type (2018-2023)
Figure 51. Manufacturing Cost Structure of Pediatric Drugs
Figure 52. Manufacturing Process Analysis of Pediatric Drugs
Figure 53. Pediatric Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount